drugset / Trial / NCT00532116

PK Comparison of 6mg and 12mg EMSAM in Elderly vs. Non-Elderly

NCT00532116

Phase 4 Completed 32 enrolled Somerset Pharmaceuticals
CrossoverOpen-labelDiagnostic

Summary

Evaluate the effect of age on the PK of two different doses of EMSAM.

Timeline

Start
2007-04
Primary completion
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Selegiline Unknown 6 mg Other
Comparator Selegiline Unknown 12 mg Other

Indications

No indication recorded.